Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI chatbot takes on minority stress: a mindfulness experiment

NCT ID NCT07732621

Symptom relief Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Aug 20, 2026 · Updated 3 times

Summary

This trial tests whether a mindfulness-centered AI chatbot can lower stress and boost mental health in Chinese men who have sex with men (MSM), a group that often faces minority stress and stigma. Participants will either use the chatbot for guided mindfulness exercises or read standard psychoeducational materials over four weeks. The study measures changes in perceived stress, emotional regulation, and symptoms of depression and anxiety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a mindfulness-centered stress management AI chatbot
What this could lead to
If effective, this chatbot could offer a low-cost, accessible tool for stress reduction in a population facing unique mental health challenges.
What could go wrong
This is a small, early-stage trial with 76 participants, so results may not apply broadly. The chatbot's effectiveness depends on user engagement and cultural adaptation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 76 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥ 18 years. 2. Chinese 3. Self-identify as MSM. 4. Own a smartphone to ensure compatibility with the intervention platform. 5. Mild to moderate perceived stress, defined as Chinese Perceived Stress Scale (PSS-14) score \< 43. Exclusion Criteria: 1. Diagnosed with an acute severe mental disorder, such as psychosis, major depressive disorder, or anxiety disorder; 2. Currently receiving psychotherapy at enrollment. 3. Report moderately severe to severe depressive symptoms, defined as a PHQ-9 total score greater than 14. 4. Unable to provide online informed consent or complete study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stress (psychology) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stress (psychology)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The University of Hong Kong

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.